ATOS — Atossa Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Atossa Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	39.6	136	111	88.5	71.1
Net Total Receivables	0.635	1.07	0.743	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	42.8	141	118	92.2	74.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.039	0.02	—	—	—
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	42.8	141	124	96.3	76.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.7	3.13	5.57	5.24	4.97
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.7	3.13	5.57	5.24	4.97
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	27.2	138	118	91	71.5
Total Liabilities & Shareholders' Equity	42.8	141	124	96.3	76.4
Total Common Shares Outstanding
Total Preferred Shares Outstanding